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Abstract
Objective: One third of patients with a major depressive episode also experience manic symptoms or, even, a (hypo)manic
episode. Retrospective studies on the temporal sequencing of symptomatology suggest that the majority of these patients
report depressive symptoms before the onset of manic symptoms. However, prospective studies are scarce and this study
will, therefore, prospectively examine the onset of either manic symptoms or a (hypo)manic episode in patients with a
major depressive disorder. In addition, we will consider the impact of a large set of potential risk factors on both outcomes.
Methodology: Four-year follow-up data were used to determine the onset of manic symptoms as well as a CIDI-based
(hypo)manic episode in a large sample (n = 889, age: 18–65 years) of outpatients with a major depressive disorder and
without manic symptoms at baseline. Baseline vulnerability (i.e., sociodemographics, family history of depression, childhood
trauma, life-events) and clinical (i.e., isolated manic symptoms, depression characteristics, and psychiatric comorbidity)
factors were considered as potential risk factors.
Results: In our sample of depressed patients, 15.9% developed manic symptoms and an additional 4.7% developed a
(hypo)manic episode during four years. Baseline isolated manic symptoms and comorbid alcohol dependence predicted
both the onset of manic symptoms and a (hypo)manic episode. Low education only predicted the onset of manic
symptoms, whereas male gender, childhood trauma and severity of depressive symptoms showed strong associations with,
especially, the onset of (hypo)manic episodes.
Conclusions: A substantial proportion (20.6%) of patients with a major depressive disorder later developed manic
symptoms or a (hypo)manic episode. Interestingly, some identified risk factors differed for the two outcomes, which may
indicate that pathways leading to the onset of manic symptoms or a (hypo)manic episode might be different. Our findings
indirectly support a clinical staging model.
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Introduction
Converging evidence from community and clinical studies
support the high prevalence of manic symptoms as well as
(hypo)manic episodes in patients with a major depressive episode
[1–2]. For example, Angst et al. [2] showed that 35% of depressed
patients reported manic symptoms and an additional 12% met
criteria for a (hypo)manic episode. The clinical relevance of
bipolarity has motivated the DSM-5 work group to not only
include bipolar disorders but also a mixed features specifier for
major depressive disorder in the new version of the DSM [3]. As
bipolar disorder often starts with depressive episodes [4], this
implies that the initial presence of a major depressive episode in
the absence of manic symptoms or a (hypo)manic episode may be
a critical phase and could therefore be a potential target for early
intervention strategies.
As much is still unclear about the underlying processes, an
essential next step would be to identify risk factors for the onset of
manic symptoms as well as a (hypo)manic episode in depressed
patients. Sociodemographics (e.g., male gender [5–6]) and other
vulnerability factors (e.g., childhood trauma [7]) have shown to be
more strongly related to bipolar disorder than to major depressive
disorder. In addition, manic symptoms [1,8], depression charac-
teristics (e.g., severity [10–11]) and psychiatric comorbidity (e.g.,
anxiety disorders or alcohol dependence [6]) are clinical factors
that have been associated with bipolarity in depressed patients. As
only few prospective studies have considered both the onset of
manic symptoms and the onset of a (hypo)manic, it is still unclear
whether risk factors differ for these outcomes.
Therefore, the present study focuses on the onset of manic
symptoms as well as a (hypo)manic episode during four years of
follow-up in a large sample of patients with a lifetime major
depressive disorder and so far without significant lifetime manic
symptoms at baseline (n = 889). We will examine whether several
vulnerability and clinical factors independently predict the onset of
manic symptoms or a (hypo)manic episode and it was, addition-
ally, tested whether risk factors differ for these two outcomes.
Methods
Study sample
Data were derived from the Netherlands Study of Depression
and Anxiety (NESDA), an ongoing cohort study aimed at
examining the long-term course and consequences of depressive
and anxiety disorders in the adult (18–65 years) population. A total
of 2,981 persons were included at the baseline assessment in 2004–
2007, consisting of healthy controls (22%) and patients with a
lifetime depressive and/or anxiety disorder (78%). To represent
various settings and stages of psychopathology, persons were
recruited from the community (19%), primary care (54%) and
outpatient mental health care services (27%). Community-based
participants had previously been identified in a population-based
study; primary care participants were identified through a three-
stage screening procedure (involving the Kessler-10 [11] and the
short-form Composite International Diagnostic Interview [CIDI]
psychiatric interview by phone) conducted among a random
sample of patients of 65 General Practitioners; and mental health
care participants were recruited consecutively when newly
enrolled at one of the 17 participating mental health organization
locations. Persons with insufficient command of the Dutch
language or a primary clinical diagnosis of bipolar disorder,
obsessive compulsive disorder, severe substance use disorder,
psychotic disorder or organic psychiatric disorder, as reported by
them or their (mental) health practitioner, were excluded. A
detailed description of the NESDA study design and sampling
procedures can be found elsewhere [12]. The research protocol
was approved by the Ethical Committee of participating
universities and all participants provided written informed
consent.
The baseline assessment consisted of an extended face-to-face
interview, including a standardized diagnostic psychiatric inter-
view, and paper-and-pencil questionnaires. For the present study,
we selected patients with a lifetime DSM-IV major depressive
disorder (n = 1,925), as assessed with the CIDI (version 2.1) at
baseline. The CIDI is highly reliable and valid [13] and was
administered by specially trained research staff. To examine the
onset of manic symptoms as well as a (hypo)manic episode, we
aimed to exclude all patients with significant lifetime manic
symptoms at baseline. Unfortunately, the CIDI section on bipolar
disorders was not conducted at baseline and, consequently, it was
not possible to determine whether patients met criteria for a DSM-
IV bipolar disorder at baseline. However, patients with a self-
reported or health care professional-reported primary clinical
diagnosis of bipolar disorder had already been excluded for the
initial participation in NESDA. In addition, we excluded all
patients with lifetime manic symptoms (n = 581) as assessed with
the Mood Disorder Questionnaire (MDQ [14–15]) or with missing
data on this measure (n = 274) at baseline. The MDQ is a fifteen-
item self-report questionnaire comprising thirteen dichotomous
items on the lifetime presence or absence of manic symptoms as
well as two additional questions regarding the clustering of
symptoms in time and severity of related problems. We considered
lifetime manic symptoms to be present when a patient reported at
least seven positive answers from the thirteen items, irrespective of
the answers on the two additional questions. Our group [16]
recently showed that this cut-off is especially adequate in detecting
a recent (i.e. past two years) (hypo)manic episode (sensitivity
= 0.83 and specificity = 0.82).
In addition to the baseline assessment, follow-up assessments
were conducted after two years (overall response rate: 87.1% [17])
and four years (overall response rate: 80.6%). In the subsample of
1,070 participants with a lifetime MDD and without lifetime
manic symptoms at baseline, 181 (16.9%) did not provide
complete data at the two-year or four-year follow-up assessments,
resulting in a sample of 889 patients for the current analyses. Non-
responders were significantly less educated (11.7 versus 12.4 years
of education, p = 0.01) compared to responders, whereas gender
(p = 0.47) and age (p = 0.45) were not associated with non-
response.
Measures
Outcome variables. In our sample, we considered the onset
of manic symptoms as well as a (hypo)manic episode during four
years of follow-up. The onset of manic symptoms was based on the
presence of seven or more positive answers on the MDQ at the
two-year or four-year follow-up assessment, in the absence of a
(hypo)manic episode. The onset of a (hypo)manic episode was
based on the presence of a DSM-IV hypomanic or manic episode
as assessed with the CIDI section on bipolar disorders at the two-
or four-year follow-up assessment.
Baseline predictors. On the basis of previously reported
associations with manic symptoms or a (hypo)manic episode, an
extensive set of potential predictors (i.e., vulnerability and clinical
factors) was selected.
1. Vulnerability factors included sociodemographics, family
history of depressive disorder, childhood trauma and life-
events at baseline.
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a. Sociodemographics included gender, age (in years) and
education (in years).
b. Family history of a unipolar or bipolar depressive episode
was assessed with the family tree method [18], which
obtains information on the presence of psychiatric disorders
among first-degree relatives (not including offspring of the
patient).
c. Based on the Childhood Trauma Inventory, a cumulative
childhood trauma index (range: 0–8) was constructed
considering the frequency (never = 0, once/sometimes
= 1, often or more = 2) of emotional neglect, psychological
abuse, physical abuse and sexual abuse before the age of 16
years [19].
d. A total count of twelve negative life events in the past year
was constructed using Brugha’s List of Threatening
Experiences [20].
2. Clinical factors included isolated manic symptoms, various
depression characteristics and psychiatric comorbidity at
baseline.
a. The number of isolated manic symptoms was defined as the
count of the thirteen dichotomous MDQ items on the
lifetime presence or absence of manic symptoms. As
patients with a total score of seven or higher were already
excluded (see sample description), the number of isolated
manic symptoms ranged from zero to six.
b. From the depression characteristics, we first considered the
age (in years) of onset of major depressive disorder as based
on CIDI questions regarding the onset of a lifetime
diagnosis at the baseline assessment. We also considered
whether patients had experienced recurrent episodes versus
a single episode during their life. The severity of depressive
symptoms in the week prior to baseline was defined as the
total score on the 30-item self-report Inventory of
Depressive Symptomatology (IDS) [21]. We also deter-
mined whether the disorder had atypical features as
assessed by specific IDS items. The atypical subtype was
defined as having mood reactivity and at least three of the
following: increased appetite, hypersomnia, leaden paraly-
sis, and interpersonal rejection sensitivity [22]. Sleep
duration was based on the average number of hours of
sleep per night during the month prior to baseline by
distinguishing short (#6 hours) versus normal (.6 hours)
duration.
c. Psychiatric comorbidity was assessed by the CIDI interview
separately considering lifetime diagnoses of any anxiety
disorder (i.e., generalized anxiety disorder, social phobia,
panic disorder, and agoraphobia) and alcohol dependence.
Statistical analyses
Analyses were conducted using SPSS version 20 statistical
software (SPSS Inc, Chicago, Illinois). In our sample of patients
with major depressive disorder and without significant lifetime
manic symptoms, we first determined the onset of manic
symptoms and a (hypo)manic episode. Then, descriptive statistics
were used to summarize the sample characteristics across these
groups. To identify independent risk factors (i.e., vulnerability and
clinical factors) of each outcome, multinomial logistic regression
analyses were performed in which predictors with a p#0.05 in
univariable analyses were entered into one multivariable analysis.
To provide insight into the nature of these associations, results of
the univariable as well as multivariable analyses were shown.
Additional logistic regression analyses were performed to test
whether predictors showed differential associations with the onset
of manic symptoms versus a (hypo)manic episode. To be able to
compare odds ratios across all continuous factors, odds ratios with




In our sample of patients with lifetime major depressive disorder
and without significant lifetime manic symptoms at baseline
(n = 889), the mean age was 43.0 (SD=12.4; range = 18–65) years
and 26.9% were men. Figure 1 shows that the onset was 15.9%
(n= 141) for manic symptoms (i.e., at least seven positive items on
the MDQ) and 4.7% (n= 42) for a DSM-IV hypomanic (n = 17) or
manic (n = 25) episode during four years of follow-up. To provide
more information about prodromal stages of bipolar disorder
patients with a (hypo)manic episode during follow-up were asked
about their age during which they first developed several manic
symptoms. The onset of manic symptoms preceded the onset of a
(hypo)manic episode with an average of 12.7 (SD=13.9) years.
This also implies that the majority (69%) of patients with a
(hypo)manic episode reported the onset of first manic symptoms
before the baseline assessment. Among patients with only manic
symptoms but no (hypo)manic episodes during follow-up, no
information about the age of onset of their first manic symptoms
was available as this was not considered in the MDQ.
Predictors of the onset of manic symptoms or a
(hypo)manic episode
Descriptive statistics (Table 1) are presented in order to explore
the role of vulnerability and clinical factors as predictors of the
onset of manic symptoms and a (hypo)manic episode, respectively.
To identify independent risk factors, a multivariable multinomial
logistic regression analysis was performed including all predictors
with a p#0.05 in the univariable analyses (both results are
presented in Table 2).
Vulnerability factors. From the sociodemographics, male
gender was a significant risk factor for the onset of both manic
Figure 1. The onset of manic symptoms as well as a
(hypo)manic episode during four years of follow-up.
doi:10.1371/journal.pone.0106871.g001
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symptoms and a (hypo)manic episode, even after adjustment for
other important vulnerability and clinical factors. Logistic
regression analyses additionally showed that this association was
stronger for a (hypo)manic episode than for manic symptoms. Low
education was only independently related with manic symptoms,
whereas childhood trauma was only independently associated with
a (hypo)manic episode. None of the other vulnerability factors
predicted the onset of manic symptomatology.
Clinical factors. The total number of isolated manic
symptoms (i.e., no more than six positive items on the MDQ)
was a strong and independent predictor of the onset of manic
symptoms as well as a (hypo)manic episode. These associations
were similar for both outcomes, which was also illustrated in
Figure 2 showing comparable dose-response relationships. In
addition, severity of depressive symptoms was an independent
predictor of both manic symptoms and (hypo)manic episodes.
However, logistic regression analyses additionally showed that this
association was stronger for the onset of a (hypo)manic episode
compared to manic symptoms (see also Figure 3). Atypical features
of depression and a short sleep duration were related to the onset
of a (hypo)manic episode in the univariable but not the
multivariable analyses, whereas none of the other depression
characteristics showed a significant association with the onset of
manic symptomatology. Comorbid alcohol dependence, but not a
comorbid anxiety disorder, was a significant predictor of both
outcomes in the univariable analyses. Although this association
remained significant for the onset of manic symptoms in the
multivariable analyses, the association with the onset of a
(hypo)manic episode only reached a borderline significance level.
Discussion
Main findings
The present study aimed to improve our knowledge about the
onset of manic symptoms as well as (hypo)manic episodes in
patients with a lifetime major depressive disorder and without
significant lifetime manic symptoms at baseline. During the
subsequent four years, 15.9% of patients had developed manic
symptoms and an additional 4.7% had developed a DSM-IV
hypomanic or manic episode. Our study also identified several
independent risk factors for the onset of manic symptoms and a
(hypo)manic episode and showed that some of these factors played
differential roles for the two outcomes.
Clinical staging models for bipolar disorders
Our study showed that a substantial proportion (i.e., 20.6%) of
patients with a diagnosis of major depressive disorder developed
manic symptoms or a (hypo)manic episode during the subsequent
four years. The presence of isolated manic symptoms was the most
important risk factor for both outcomes, which is in line with a
recent study demonstrating that these symptoms are a precursor of
a later (hypo)manic episode [8]. In addition, patients who had
developed a (hypo)manic episode during follow-up retrospectively
reported that the presence of manic symptoms had preceded the
onset of the full-blown episode with an average of thirteen years.
These findings support a clinical staging model in which manic
symptoms may increase over time and eventually result in a
(hypo)manic episode [23–26].
Our findings further showed that depression severity was an
important risk factor for the onset of manic symptoms and,
Table 1. Sample characteristics.
Onset of manic symptomatology
Manic (Hypo)manic
Unipolar depression symptoms episode
(n =706) (n =141) (n=42)
Mean (sd)/% Mean (sd)/% Mean (sd)/%
Vulnerability factors
Gender (male) 23.8% 35.5% 57.1%
Age in years 43.1 (12.6) 42.3 (11.9) 43.5 (11.2)
Education in years 12.6 (3.2) 11.4 (3.1) 11.8 (3.5)
Family history of depressive disorder (yes) 71.7% 78.7% 78.6%
Severity of childhood trauma 1.6 (2.0) 1.8 (2.2) 2.9 (2.3)
Number of life events 0.8 (1.0) 0.8 (1.0) 0.9 (1.2)
Clinical factors
Number of manic symptoms 3.0 (1.9) 4.3 (1.7) 4.2 (1.6)
Age of onset of MDD 28.5 (12.6) 28.2 (12.2) 28.2 (12.3)
Recurrent MDD (yes) 53.4% 50.4% 45.2%
Severity of depressive symptoms 21.7 (12.9) 26.2 (13.0) 33.4 (11.7)
Atypical depression subtype (yes) 9.6% 12.1% 26.2%
Short sleep duration (yes) 30.9% 30.5% 50.0%
Anxiety disorder (yes) 65.0% 69.5% 71.4%
Alcohol dependence (yes) 11.8% 19.9% 26.2%
doi:10.1371/journal.pone.0106871.t001
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especially, a (hypo)manic episode. This is in line with previous
studies on bipolar disorders [2,9–10] and, again, supports a clinical
staging model in which patients with a major depressive disorder,
and especially those who have progressed to a more severe
subtype, have an increased risk of developing manic symptoms or
a (hypo)manic episode [23–26]. This was also indirectly supported
by our finding that comorbid alcohol dependence was a risk factor
for both outcomes. The presence of alcohol dependence is known
to be especially high in severe subtypes of major depressive
disorder [27] and, as expected, reported associations with manic
symptoms or a (hypo)manic episode decreased substantially after
adjustment for baseline depression severity. Nonetheless, comorbid
alcohol dependence could be an important indicator for both
outcomes and screening instruments, such as the Alcohol Use
Disorders Identification Test [28–29], may help to identify these
high risk patients.
Onset rates of (hypo)manic episodes
In our sample of depressed outpatients, an average of 1.2% had
developed a (hypo)manic episode per year during follow-up. This
annual onset rate is smaller than, for example, the 2.8% that was
observed in depressed outpatients in Finland [10] and the 3.1% in
hospitalized inpatients in the United States [30]. These contrasting
findings may be explained by methodological differences. Our
study, for example, excluded all patients with significant manic
symptoms at baseline, as assessed with a screening instrument for
manic symptoms. In contrast, the two previous studies excluded
patients with a (hypo)manic episode, as assessed with a clinical
interview, but did not consider baseline manic symptoms [10,30].
Consequently, these samples may have included some patients
with subthreshold manic symptoms, which could have resulted in
higher onset rates of (hypo)manic episodes.
In addition, primary diagnoses of obsessive compulsive disorder,
severe substance use disorder or psychotic disorder were all
exclusion criteria for our study, but not for the two previous
studies. As some of these factors might be risk factors for the onset
of manic symptoms or a (hypo)manic episode [8,30], onset rates in
these studies are likely to be higher. An additional methodological
difference is that our sample consisted of adults with a mean age of
43.0 years, which is comparable to the 40.2 years in the study of
Holma et al. [10] but is much older than the 23.0 years in the
sample of Goldberg et al. [30]. Although the majority of bipolar
disorders typically develops earlier in life (i.e., before the age of 30
years), an additional peak of onset rates has been observed
between 35 and 45 years of age [31]. The development of a
(hypo)manic episode in our study should therefore be considered
as a late-onset (hypo)manic episode and may be different from
(hypo)manic episodes that develop earlier in life [31–32] (see also
the ‘Risk factors’ section).
Risk factors
Our study is unique in simultaneously examining the indepen-
dent effects of several clinical as well as vulnerability factors on the
onset of manic symptoms versus a (hypo)manic episode. From the
clinical factors, the number of isolated manic symptoms and
comorbid alcohol dependence tend to show similar associations
with the onset of manic symptoms and a (hypo)manic episode,
which may indicate that these factors play similar roles. However,
the severity of depressive symptoms may be more important for
the onset of a (hypo)manic episode compared to manic symptoms
as the association with the first was stronger than with the latter. A
similar pattern was found for male gender, as a vulnerability
factor, which was an independent risk factor for the onset of manic
symptoms and, especially, for a (hypo)manic episode. This is in line
with previous studies showing that patients with increasing manic
symptomatology were more often male [1,5–6,33]. We also found
that childhood trauma independently predicted the onset of a
(hypo)manic episode, which corroborates previous cross-sectional
findings [7], but not the onset of manic symptoms. In contrast, low
education predicted the onset of manic symptoms, but not a
(hypo)manic episode. Although more research is needed, these
findings are intriguing as they may indicate that processes
underlying the onset of manic symptoms or the onset of a
(hypo)manic episode might be different.
Our study also showed that family history of depressive
disorders as well as an early onset of MDD were not related to
the onset of manic symptoms or a (hypo)manic episode. This
Figure 2. Baseline number of isolated manic symptoms
predicting the onset of manic symptoms as well as a
(hypo)manic episode during four years of follow-up.
doi:10.1371/journal.pone.0106871.g002
Figure 3. Baseline severity of depressive symptoms predicting
the onset of manic symptomatology during four years of
follow-up.
doi:10.1371/journal.pone.0106871.g003
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contradicts the findings of previous studies showing strong
associations between these factors and bipolar disorder [8–10].
As genetic vulnerability may be more important for early-onset
compared to late-onset bipolarity [31–32], this may explain the
non-significant findings of our study mainly focussing on late-onset
manic symptoms or a (hypo)manic episode. Future studies
including both younger and older patients are necessary to
determine whether etiological pathways for the development of
early- versus late-onset manic symptoms or a (hypo)manic episode
indeed differ.
Strengths and limitations
Our study has both strengths and limitations. Methodological
strengths are that we were one of the first studies that could
prospectively examine the onset of manic symptoms as well as a
(hypo)manic episode. In addition, we included a large sample
(n = 889) of patients with a DSM-IV diagnosis of major depressive
disorder without lifetime manic symptoms at baseline and tested
the independent effects of several potential risk factors. Although
we assessed various potential predictors of manic symptomatology,
we did not have information about some well-known risk factors
such as a family history of bipolar disorder [8–9] or psychotic
symptoms [8,30]. Although these factors may be less important for
late-onset manic symptoms or (hypo)manic episodes (i.e. focus of
our study) [31–32], we would like to encourage future researchers
to gather this information, also in older samples of depressed
patients.
Another important limitation is that the CIDI section on bipolar
disorders was not conducted at baseline and, consequently,
information about DSM-IV (hypo)manic episodes was not
available at that time. However, patients with a baseline self-
reported or health care professional-reported diagnosis of bipolar
disorder were excluded from the study as well as patients with
significant lifetime manic symptoms as assessed with the MDQ.
Previous studies have shown mixed results regarding the validity of
the MDQ (see [34] for a thorough review of the literature) and
these inconsistencies might have resulted from recall bias (a
patient’s recall of recent symptoms is likely to be more reliable
than recall of symptoms earlier in life). This was also demonstrated
by a recent study of our group, in which we showed that the MDQ
was adequate for detecting recent (hypo)manic episodes but not for
lifetime episodes [16]. Consequently, our sample may have
included some patients with a history of manic symptoms or,
even, a (hypo)manic episode and this might have impacted our
results. On the other hand, our sample may be similar to depressed
patients in clinical practice as a history of manic symptoms or a
(hypo)manic episode is often not recognized by patients or health
care professionals [35–36]. The time lag between initial help
seeking and the correct diagnosis is often more than ten years
[37,38] and, therefore, misdiagnosis of bipolar disorder is a major
problem for both clinicians and researchers.
Conclusions
In conclusion, 15.9% of patients with a major depressive
disorder had developed manic symptoms and an additional 4.7%
had developed a (hypo)manic episode during four years of follow-
up. The number of isolated manic symptoms at baseline was an
important, independent predictor of both stages in the develop-
ment of bipolar disorder. This study also identified several other
independent risk factors and demonstrated that some risk factors
were different for the two outcomes.
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